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ABSTRACT
Brachytherapy is a common treatment modality used for treating prostate cancer.
The radiation is emitted from within the prostate, which focuses the damage on the tu-
mour rather than the surrounding healthy tissue. However, due to the close proximity of
the rectum to the prostate, there is a possibility that the rectum will receive too much radi-
ation dose during prostate treatment. This may lead to post-treatment rectal complications
that range in severity from general rectal discomfort and bleeding, to the development of
a rectal fistula that may require surgical intervention. Currently, there is no real-time
quality assurance tool used to verify that the rectum does not receive too much radiation
dose.
The Centre for Medical Radiation Physics (CMRP) at the University of Wollon-
gong, Australia, has developed a new MOSFET dosimeter called the MOSkin with a
unique packaging design that should demonstrate some benefits over other MOSFET
dosimeters. The MOSkin can potentially serve as a real-time rectal dosimeter for use
during a PDR or HDR brachytherapy treatment.
The general aim of this research is to characterise the performance of the new
MOSkin dosimeter, and to determine whether the unique design of the MOSkin demon-
strates dosimetric advantages over other dosimeters for brachytherapy, and in certain
other applications. The performance characteristics of the MOSkin were explored by
exposing it to a 6 MV x-ray field delivered by a linear accelerator (LINAC), and also
with an Ir-192 PDR brachytherapy source.
The MOSkin was irradiated with a 6 MV, 10×10 cm3 photon beam with the gantry
set to 100 cm source-to-surface distance, and its dose response was compared to the re-
sponse of a CC13 compact ionization chamber, and a couple of fiber optic dosimeters.
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The fiber optic dosimeters had either a 0.5 or 1 mm diameter scintillating crystal attached
to one end of the optical fiber. The MOSkin’s ability to measure the skin dose to a depth
of 0.07 mm, which corresponds to the nominal depth of the basal cell layer of the epider-
mis, was compared to Attix chamber and fiber optic dosimeter measurements, along with
skin dose measurements reported in other studies found in the literature. My research
was primarily concerned with dosimetry at shallow depths in the phantom because it
was believed that the MOSkin’s packaging design would prove advantageous over other
dosimeters at such depths.
With regards to brachytherapy, the dose response of the MOSkin was compared to
the response of a RADFET dosimeter within a rectal phantom. Brachytherapy treatment
planning systems (TPS) calculate the dose by assuming that the human body is a large,
homogeneous water-equivalent material. The effect that a hollow, air-filled rectal cavity
has on the anterior rectal dose was investigated by measuring the dose delivered to the
inner wall of a rectal phantom while it was empty, and comparing dose measurement to
the dose measured within a homogeneous rectal phantom, and the dose calculated by the
TPS. The results were also corroborated by Monte Carlo simulations written with the
Geant4 toolkit.
The results of an early stage, Phase II clinical trial at St. George Cancer Care Centre
are discussed. The MOSkin was used to measure the dose delivered to the anterior wall of
the patient’s rectum during PDR brachytherapy patients during treatment, and the results
are compared to the dose calculated by the TPS. The results were also compared to the
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